Aethlon Medical Inc [NASDAQ: AEMD] slipped around -0.02 points on Wednesday, while shares priced at $1.11 at the close of the session, down -1.77%.
Aethlon Medical Inc stock is now -65.79% down from its year-to-date (YTD) trading value. AEMD Stock saw the intraday high of $1.14 and lowest of $1.09 per share. The company’s 52-week high price is 8.44, which means current price is +2.34% above from all time high which was touched on 01/06/25.
Compared to the average trading volume of 268.96K shares, AEMD reached a trading volume of 43459 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Aethlon Medical Inc [AEMD]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for AEMD shares is $3.02 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AEMD stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Aethlon Medical Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on July 07, 2025.
The Price to Book ratio for the last quarter was 0.84, with the Price to Cash per share for the same quarter was set at 1.45.
How has AEMD stock performed recently?
Aethlon Medical Inc [AEMD] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -9.76. With this latest performance, AEMD shares dropped by -17.16% in over the last four-week period, additionally sinking by -77.80% over the last 6 months – not to mention a drop of -83.87% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AEMD stock in for the last two-week period is set at 37.95, with the RSI for the last a single of trading hit 0.0875, and the three-weeks RSI is set at 0.1199 for Aethlon Medical Inc [AEMD]. The present Moving Average for the last 50 days of trading for this stock 1.3605, while it was recorded at 1.1440 for the last single week of trading, and 3.1851 for the last 200 days.
Aethlon Medical Inc (AEMD) Capital Structure & Debt Analysis
According to recent financial data for Aethlon Medical Inc. ( AEMD), the Return on Equity (ROE) stands at -207.29%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -150.45%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Aethlon Medical Inc’s Return on Invested Capital (ROIC) is -341.94%, showcasing its effectiveness in deploying capital for earnings.
Aethlon Medical Inc (AEMD) Efficiency & Liquidity Metrics
Based on Aethlon Medical Inc’s (AEMD) latest financial statements, the Debt-to-Equity Ratio is 0.20%, indicating its reliance on debt financing relative to shareholder equity.
Aethlon Medical Inc (AEMD) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Aethlon Medical Inc. (AEMD) effectively leverages its workforce, generating an average of -$1397777.78 per employee. The company’s liquidity position is robust, with a Current Ratio of 2.48% and a Quick Ratio of 2.48%, indicating strong ability to cover short-term liabilities.
Earnings analysis for Aethlon Medical Inc [AEMD]
With the latest financial reports released by the company, Aethlon Medical Inc posted -1.6/share EPS, while the average EPS was predicted by analysts to be reported at -1.56/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.04. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for AEMD. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Aethlon Medical Inc go to 61.49%.
Insider trade positions for Aethlon Medical Inc [AEMD]
There are presently around $15.44%, or 15.53%% of AEMD stock, in the hands of institutional investors. The top three institutional holders of AEMD stocks are: SUSQUEHANNA INTERNATIONAL GROUP, LLP with ownership of 36652.0 shares, which is approximately 0.4915%. TWO SIGMA SECURITIES, LLC, holding 34544.0 shares of the stock with an approximate value of $$17227.0 in AEMD stocks shares; and TWO SIGMA SECURITIES, LLC, currently with $$13170.0 in AEMD stock with ownership which is approximately 0.3541%.
